Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load - PubMed (original) (raw)

. 2017 Aug;67(2):237-245.

doi: 10.1016/j.jhep.2017.03.020. Epub 2017 Mar 29.

Maximilian Deest 2, Anna T X Nguyen 2, Frauke Stanke 3, Dirk Heckl 4, Rui Costa 2, Axel Schambach 5, Michael P Manns 6, Thomas Berg 7, Florian W R Vondran 8, Christoph Sarrazin 9, Sandra Ciesek 1, Thomas von Hahn 10

Affiliations

• PMID: 28363797
• DOI: 10.1016/j.jhep.2017.03.020

Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load

Sandra Westhaus et al. J Hepatol. 2017 Aug.

Abstract

Background & aims: There are numerous coding and non-coding variants in the SCARB1 gene that encodes scavenger receptor class B member 1 (SR-BI), a key receptor for both high density lipoproteins and hepatitis C virus (HCV). Many have been linked to clinical phenotypes, yet their impact on the HCV replication cycle is incompletely understood. The aim of this study was to analyze the impact of these variants on the molecular biology and clinical course of HCV.

Methods: We analyzed key coding non-synonymous as well as non-coding SCARB1 variants using virological in vitro and human genetics approaches.

Results: Non-synonymous variants: S112F and T175A have greatly reduced HCV receptor function. When present on the cell surface, these variants are impaired in their ability to interact with HCV E2. Non-coding variants: The G allele in rs3782287 is associated with decreased viral load. Haplotype analysis confirmed these findings and identified haplotype rs3782287 A/rs5888 C as a risk allele associated with increased viral load. We also detected a trend towards lower hepatic SR-BI expression in individuals with the rs3782287 GG genotype associated with low viral load suggesting a potential underlying mechanism.

Conclusion: Coding and non-coding genetic SCARB1 variants modulate the HCV replication cycle and possibly clinical features of hepatitis C. These findings underscore the relevance of SR-BI as an HCV receptor and contribute to our understanding of inter-individual variation in HCV infection.

Lay summary: The cell surface receptor SR-BI (scavenger receptor class B member 1), is essential for hepatitis C virus (HCV) entry into hepatocytes. Variations in the gene coding this receptor influence infectivity and viral load. We analyzed these variations to gain a better understanding of inter-individual differences over the course of HCV infection.

Keywords: Haplotype; Hepatitis C virus (HCV); SCARB1 gene; Scavenger receptor class B type I (SR-BI); Single nucleotide polymorphism (SNP).

Copyright © 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

PubMed Disclaimer

Comment in

• SCARB1 variants and HCV infection: Host susceptibility is lost in translation.
  Colpitts CC, Baumert TF. Colpitts CC, et al. J Hepatol. 2017 Aug;67(2):211-213. doi: 10.1016/j.jhep.2017.04.013. Epub 2017 May 4. J Hepatol. 2017. PMID: 28478119 Free PMC article. No abstract available.

Similar articles

• Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model.
  Gao R, Gao W, Xu G, Xu J, Ren H. Gao R, et al. World J Gastroenterol. 2017 Jul 28;23(28):5158-5166. doi: 10.3748/wjg.v23.i28.5158. World J Gastroenterol. 2017. PMID: 28811710 Free PMC article.
• A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.
  Zuiani A, Chen K, Schwarz MC, White JP, Luca VC, Fremont DH, Wang D, Evans MJ, Diamond MS. Zuiani A, et al. J Virol. 2016 Nov 14;90(23):10499-10512. doi: 10.1128/JVI.01011-16. Print 2016 Dec 1. J Virol. 2016. PMID: 27630236 Free PMC article.
• Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants.
  Catanese MT, Ansuini H, Graziani R, Huby T, Moreau M, Ball JK, Paonessa G, Rice CM, Cortese R, Vitelli A, Nicosia A. Catanese MT, et al. J Virol. 2010 Jan;84(1):34-43. doi: 10.1128/JVI.02199-08. J Virol. 2010. PMID: 19828610 Free PMC article.
• Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation.
  Dao Thi VL, Dreux M, Cosset FL. Dao Thi VL, et al. Expert Rev Mol Med. 2011 Apr 14;13:e13. doi: 10.1017/S1462399411001785. Expert Rev Mol Med. 2011. PMID: 21489334 Review.
• The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
  Perrault M, Pécheur EI. Perrault M, et al. Biochem J. 2009 Oct 12;423(3):303-14. doi: 10.1042/BJ20091000. Biochem J. 2009. PMID: 19807698 Review.

Cited by

• A Synopsis of Hepatitis C Virus Treatments and Future Perspectives.
  Medina C, García AH, Crespo FI, Toro FI, Mayora SJ, De Sanctis JB. Medina C, et al. Curr Issues Mol Biol. 2023 Oct 11;45(10):8255-8276. doi: 10.3390/cimb45100521. Curr Issues Mol Biol. 2023. PMID: 37886964 Free PMC article. Review.
• Scavenger receptor class B type I genetic variants associated with disease severity in chronic hepatitis C virus infection.
  Arandhara VL, McClure CP, Tarr AW, Chappell S, Morgan K, Baumert TF, Irving WL, Ball JK. Arandhara VL, et al. J Med Virol. 2023 Jan;95(1):e28331. doi: 10.1002/jmv.28331. J Med Virol. 2023. PMID: 36415047 Free PMC article.
• Neutralization and receptor use of infectious culture-derived rat hepacivirus as a model for HCV.
  Wolfisberg R, Thorselius CE, Salinas E, Elrod E, Trivedi S, Nielsen L, Fahnøe U, Kapoor A, Grakoui A, Rice CM, Bukh J, Holmbeck K, Scheel TKH. Wolfisberg R, et al. Hepatology. 2022 Nov;76(5):1506-1519. doi: 10.1002/hep.32535. Epub 2022 May 12. Hepatology. 2022. PMID: 35445423 Free PMC article.
• SR-B1's Next Top Model: Structural Perspectives on the Functions of the HDL Receptor.
  Powers HR, Sahoo D. Powers HR, et al. Curr Atheroscler Rep. 2022 Apr;24(4):277-288. doi: 10.1007/s11883-022-01001-1. Epub 2022 Feb 2. Curr Atheroscler Rep. 2022. PMID: 35107765 Free PMC article. Review.
• Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate Cancer.
  Pandey M, Cuddihy G, Gordon JA, Cox ME, Wasan KM. Pandey M, et al. Pharmaceutics. 2021 Sep 18;13(9):1509. doi: 10.3390/pharmaceutics13091509. Pharmaceutics. 2021. PMID: 34575583 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program